SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies

被引：3
|
作者：
Ryan, Maureen C. [1 ]
Schimpf, Brian [1 ]
Anderson, Martha [1 ]
Zeng, Weiping [1 ]
Emmerton, Kim [1 ]
Miyamoto, Jamie [1 ]
Kostner, Heather [1 ]
Yu, Changpu [1 ]
Van Epps, Heather [1 ]
Tatalick, Laurie [1 ]
Benjamin, Dennis [1 ]
机构：
[1] Seattle Genet Inc, Translat Res, Bothell, WA USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.594.594
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies
    Ryan, Maureen C.
    Palanca-Wessels, Maria Corinna
    Schimpf, Brian
    Gordon, Kristine A.
    Kostner, Heather
    Meyer, Brad
    Yu, Changpu
    Van Epps, Heather A.
    Benjamin, Dennis
    BLOOD, 2017, 130 (18) : 2018 - 2026
  • [2] Preclinical characterization of an auristatin-based anti-CD19 drug conjugate, SGN-19A
    Law, Che-Leung
    Sutherland, May
    Miyamoto, Jamie
    Hayes, Dawn
    Duniho, Steve
    Boursalian, Tamar
    Stone, Ivan
    Jonas, Mechthild
    Smith, Leia
    Benjamin, Dennis
    CANCER RESEARCH, 2011, 71
  • [3] SGN-CD19A: A novel Anti-CD19 antibody drug conjugate
    Albertson, Tina M.
    Sandalic, Lali
    Zhao, Baiteng
    Kostic, Ana
    Law, Che-Leung
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies.
    Gerber, Hans-Peter
    Morris-Tilden, Carol
    Stone, Ivan
    Jonas, Mechthild
    Kung-Sutherland, May
    Miyamoto, Jamie
    Brown, Lindsay
    Westendorf, Lori
    Meyer, Damon
    Sussman, Django
    Carter, Paul
    Law, Che-Leung
    Grewal, Iqbal S.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3451S - 3451S
  • [5] Pre-Clinical Development of Adct-402, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate (ADC) Targeting CD19-Expressing B-Cell Malignancies
    Zammarchi, Francesca
    Williams, David G.
    Adams, Lauren
    Havenith, Karin
    Chivers, Simon
    D'Hooge, Francois
    Howard, Philip W.
    Hartley, John A.
    van Berkel, Patrick H.
    BLOOD, 2015, 126 (23)
  • [6] The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies
    Cao, Jun-Xia
    Gao, Wei-Jian
    You, Jia
    Wu, Li-Hua
    Liu, Jin-Long
    Wang, Zheng-Xu
    CYTOTHERAPY, 2019, 21 (07) : 769 - 781
  • [7] Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies
    Yang, Xingcheng
    Wei, Jia
    Zhou, Jianfeng
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 821 - 834
  • [8] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Cardarelli, Pina M.
    Rao-Naik, Chetana
    Chen, Sharline
    Huang, Haichun
    Pham, Amie
    Moldovan-Loomis, Maria-Cristina
    Pan, Chin
    Preston, Ben
    Passmore, David
    Liu, Jie
    Kuhne, Michelle R.
    Witte, Alison
    Blanset, Diann
    King, David J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 257 - 265
  • [9] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Pina M. Cardarelli
    Chetana Rao-Naik
    Sharline Chen
    Haichun Huang
    Amie Pham
    Maria-Cristina Moldovan-Loomis
    Chin Pan
    Ben Preston
    David Passmore
    Jie Liu
    Michelle R. Kuhne
    Alison Witte
    Diann Blanset
    David J. King
    Cancer Immunology, Immunotherapy, 2010, 59 : 257 - 265
  • [10] A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
    Caroline S Breton
    Aimable Nahimana
    Dominique Aubry
    Julie Macoin
    Pierre Moretti
    Martin Bertschinger
    Samuel Hou
    Michel A Duchosal
    Jonathan Back
    Journal of Hematology & Oncology, 7
12345